Kevonne Holloway, MBA, managing director, Global Content Partners, Elsevier, is one of 12 winners in this year's Emerging Leaders in Healthcare feature. In an interview with MHE, Holloway recommended "The Light We Carry," a book by Michelle Obama, as a must-read as it describes how everyone has a light inside of them that illuminates the way for others.
Kevonne Holloway, MBA, managing director, Global Content Partners, Elsevier, is one of 12 winners in this year's Emerging Leaders in Healthcare feature. In an interview with MHE, Holloway recommended "The Light We Carry," a book by Michelle Obama, as a must-read as it describes how everyone has a light inside of them that illuminates the way for others.
Holloway added that if more people working in healthcare practiced kindness and empathy, people would have better healthcare experiences. Aside from her book recommendation, Holloway also shared a guilty pleasure and advice that really turned her career around.
Two Opdivo Updates from Bristol Myers Squibb
May 14th 2024First approved by the U.S. Food and Drug Administration (FDA) in 2014, Opdivo has multiple indications across various types of cancer, including NSCLC, melanoma, renal cell carcinoma, Hodgkin lymphoma, squamous cell carcinoma of the head and neck, and urothelial carcinoma.
Read More
This data is based off of a study conducted by a group of researchers led by Niklas Frahm from the German Multiple Sclerosis Registry to compare the characteristics of patients with MS who switched from their first disease-modifying therapies (DMT) with those of patients who continued taking their first DMT.
Read More